In addition, Mizenko et al. [29] found that only 20% of sEVs isolated from the serum of ovarian cancer patients expressed CD81 compared to CD63 and CD9 which were expressed on 30% and 60%, respectively. This evidence concerns the gene CD63 and ovarian carcinoma.